Why some scientists think the AstraZeneca vaccine is still useful for South Africa
Why some scientists think the AstraZeneca vaccine is still useful for South Africa. Photo: iStockPhoto

With some (but not all) countries in the European Union temporarily suspending the use of the AstraZeneca COVID-19 vaccine as a precautionary measure – based on reports of rare blood coagulation disorders (blood clots) in some people who had received the vaccine – the World Health Organisation (WHO) has released the following statement.

“Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally.

“In extensive vaccination campaigns, it is routine for countries to signal potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them. It also shows that the surveillance system works and that effective controls are in place.

“WHO is in regular contact with the European Medicines Agency and regulators around the world for the latest information on COVID-19 vaccine safety. The WHO COVID-19 Subcommittee of the Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine. Once that review is completed, WHO will immediately communicate the findings to the public.

“At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue,” the statement concluded.